Style | Citing Format |
---|---|
MLA | Fakhrieh Kashan Z, et al.. "Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran." Clinical Epidemiology and Global Health, vol. 30, no. , 2024, pp. -. |
APA | Fakhrieh Kashan Z, Kia EB, Haghi Ashtiani MT, Dabaghi SR, Sari MA, Darabi E (2024). Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran. Clinical Epidemiology and Global Health, 30(), -. |
Chicago | Fakhrieh Kashan Z, Kia EB, Haghi Ashtiani MT, Dabaghi SR, Sari MA, Darabi E. "Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran." Clinical Epidemiology and Global Health 30, no. (2024): -. |
Harvard | Fakhrieh Kashan Z et al. (2024) 'Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran', Clinical Epidemiology and Global Health, 30(), pp. -. |
Vancouver | Fakhrieh Kashan Z, Kia EB, Haghi Ashtiani MT, Dabaghi SR, Sari MA, Darabi E. Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran. Clinical Epidemiology and Global Health. 2024;30():-. |
BibTex | @article{ author = {Fakhrieh Kashan Z and Kia EB and Haghi Ashtiani MT and Dabaghi SR and Sari MA and Darabi E}, title = {Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran}, journal = {Clinical Epidemiology and Global Health}, volume = {30}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Fakhrieh Kashan Z AU - Kia EB AU - Haghi Ashtiani MT AU - Dabaghi SR AU - Sari MA AU - Darabi E TI - Seroprevalence of Strongyloidiasis and Toxocariasis Among Hypereosinophilic Patients Seeking Care at Diagnostic Centers in Tehran, Iran JO - Clinical Epidemiology and Global Health VL - 30 IS - SP - EP - PY - 2024 ER - |